Cytosine arabinoside-induced vasculitis

Mayo Clinic Proceedings

Volumn 73, Issue 3, 1998, Pages 239-242

  Ahmed, Iftikhar ^a   Chen, Ko Ron ^b   Nakayama, Hideo ^c   Gibson, Lawrence E ^b  

^a MAYO CLINIC ROCHESTER   (United States)

^b SAISEIKAI CENTRAL HOSPITAL   (Japan)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE;

ACUTE NONLYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; BLOOD VESSEL INJURY; CASE REPORT; ENDOTHELIUM CELL; FEMALE; HUMAN; NECROTIZING ARTERITIS; SYSTEMIC VASCULITIS; VASCULAR DISEASE; VASCULITIS;

EID: 0031913838     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/73.3.239     Document Type: Article

References (16)

1. Bodey GP, Freireich EJ, Monto RW, Hewlett JS. Cytosine arabinoside (NSC-63878) therapy for acute leukemia in adults. Cancer Chemother Rep 1969;53:59-66
2. Bodey GP, Coltman CA, Hewlet JS, Freireich EJ. Progress in the treatment of adults with acute leukemia: review of regimens containing cytarabine studied by the Southwest Oncology Group. Arch Intern Med 1976;136:1383-1388
3. Calabresi P, Chabner BA. Antineoplastic agents. In: Oilman AG, Rail TW, Nies AS, Taylor P, editors. Goodman and Oilman's the Pharmacological Basis of Therapeutics. 8th ed. New York: Pergamon Press; 1990. pp 1230-1232
4. Baack BR, Burgdorf WHC. Chemotherapy-induced acral erythema. J Am Acad Dermatol 1991;24:457-461
5. Horwitz U, Dreizen S. Acral erythemas induced by chemotherapy and graft-versus-host disease in adults with hematogenous malignancies. Cutis 1990;46:397-404
6. Rynn TC, Harrist TJ, Murphy GF, Loss RW, Moschella SL Neutro philic eccrine hidradenitis: a distinctive rash associated with cytarabine therapy and acute leukemia. J Am Acad Dermatol 1984;11:584-590
7. Greenbaum BH, Heymann WR, Reid CS, Travis SF, Donaldson MH. Chemotherapy-associated eccrine hidradenitis: neutrophilic eccrine hidradenitis reevaluated; the role of neutrophilic infiltration. Med Pediatr Oncol 1988;16:351-355
8. Hurt MA, Halvorson RD, Petr FC Jr, Cooper JT Jr, Friedman DJ. Eccrine squamous syringometaplasia: a cutaneous sweat gland reaction in the histologie spectrum of 'chemotherapy-associated eccrine hidradenitis' and 'neutrophilic eccrine hidradenitis.' Arch Dermatol 1990:126:73-77
9. Cordonnier C, Roujeau JC, Vernant JP, Matheron S, Ganem G. Cancer chemotherapy and acral erythema [letter]. Ann Intern Med 1982;97:783
10. Denefrio JM, Kaplan RS, Eisenberger MA, Lessner HE. Phase II study of cyclophosphamide and cytarabine in the treatment of metastatic adenocarcinoma of the colon and rectum [letter]. Cancer Treat Rep 1981:65:163-164
11. Herzig RH, Wolff SN, Lazarus HM, Phillips GL, Karanes C, Herzig GP. High-dose cytosine arabinoside therapy for refractory leukemia. Blood 1983:62:361-369
12. Levine N, Greenwald ES. Mucocutaneous side effects of cancer chemotherapy. Cancer Treat Rev 1978;5:67-84
13. Kechijian P, Sadick NS, Mariglio J, Schulman P. Cytarabine-induced inflammation in the seborrheic kératoses of Leser-Trélat. Ann Intern Med 1979:91:868-869
14. Upjohn Company. Cytarabine (Cytosar). Clin Pharmacol Ther 1970:11:155-160
15. Hippe E, Jensson V, Schröder HD, Jensen TS. Ara-C vasculitis [letter]. EurJHaematol 1988;41:96
16. Boogaerts MA, Malbrain S, Verwilghen RL. The Ara-C syndrome: direct endothelial cytotoxicity [abstract]. Br J Haematol 1987;66: 423